WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

C CARDIOVASCULAR SYSTEM

This group comprises substances used for the treatment of cardiovascular conditions.
Drugs used for the treatment of hypertension are classified in C02 - Antihypertensives, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers, and C09 - Agents acting on the renin-angiotensin system. For the classification of combination products of antihypertensives from different ATC groups, the following ranking should be used, from higher to lower precedence: C09, C07, C08, and C03.


C02 ANTIHYPERTENSIVES

See also C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers and C09 - Agents acting on the renin-angiotensin system.
Antihypertensives are mainly classified at 3rd levels according to the mechanism of action. Most headings are self-explanatory:
C02A Antiadrenergic agents, centrally acting
C02B Antiadrenergic agents, ganglion-blocking
C02C Antiadrenergic agents, peripherally acting
C02D Arteriolar smooth muscle, agents acting on
C02K Other antihypertensives
C02L Antihypertensives and diuretics in combination
C02N Combinations of antihypertensives in ATC gr. C02

The oral DDDs are based on the average doses needed to reduce the blood pressure to a normal level in patients with mild-moderate hypertension.
Parenteral DDDs are based on dosages used for the treatment of hypertensive crises and are based on the content of the active ingredient pr. vial (ampoule).


C02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
C02B ANTIADRENERGIC AGENTS, GANGLION-BLOCKING
C02C ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING

Alpha- and beta-blocking agents, see C07AG.

C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON

See also C08 - Calcium channel blockers.

C02K OTHER ANTIHYPERTENSIVES

This group comprises all antihypertensives which cannot be classified in groups C02A-D, C02L, C02N, C03 - Diuretics, C07 - Beta blocking agents, C08 - Calcium channel blockers or C09 - Agents acting on the renin-angiotensin system.

C02L ANTIHYPERTENSIVES AND DIURETICS IN COMBINATION

All substances classified in groups C02A-K, in combination with diuretics are classified in this group. At each 5th level, various combinations containing e.g. different diuretics, other antihypertensives or potassium may occur.
Combinations with beta blocking agents, see comments under C07.
Diuretics in combination with calcium channel blockers are classified in C08.
Diuretics in combination with ACE inhibitors, are classified in C09BA.
Diuretics in combination with angiotensin II reseptor blockers (ARBs) are classified in C09DA.
The need for a systematic approach to classify combinations of different antihypertensives has resulted in a ranking according to the ATC codes. Substances classified in ATC group C02AA take precedence over C02AB and substances in C02A take precedence over C02B etc.
Example: A combined preparation containing bietaserpine, hydralazine and hydrochlorothiazide will be given the code C02LA07 according to the above mentioned ranking.
Combinations with psycholeptics are classified at separate 5th levels using the corresponding 70-series.

It has been considered most appropriate to assign fixed DDDs based on the average use of the different combinations without considering and comparing the strengths of the various components. 1 tablet is the fixed DDD for products given once daily whereas the fixed DDD for products given twice daily and three times daily is respectively
2 tablets and 3 tablets. The assigned DDDs cannot always be compared with the DDDs assigned for plain preparations.

C02N COMBINATIONS OF ANTIHYPERTENSIVES IN ATC-GR. C02

Comprises combinations of different antihypertensives classified in ATC-gr. C02.
Antihypertensives in combination with diuretics are classified in C02L - Antihypertensives and diuretics in combination.
Combinations with beta blocking agents, see C07F - Beta blocking agents, other combinations.

The DDDs for fixed combinations are commented in C02L.

Last updated: 2024-01-26